一代和三代EGFR-TKI联合用药有效治疗携带EGFR-T790M和反式C797S的肺腺癌

    Lung Adenocarcinoma Harboring EGFR T790M and in Trans C797S Responds to Combination Therapy of First and Third Generation EGFR-TKIs and Shifts Allelic Configuration at Resistance

    /

    返回文章
    返回